REGULUS THERAPEUTICS INC - COM NEW (RGLS)

CUSIP: 75915K200

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / COM NEW
Total 13F shares
27,287,166
Share change
+8,876,766
Total reported value
$42,568,129
Put/Call ratio
32%
Price per share
$1.56
Number of holders
42
Value change
+$14,984,655
Number of buys
28
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 75915K200?
CUSIP 75915K200 identifies RGLS - REGULUS THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of REGULUS THERAPEUTICS INC - COM NEW (RGLS) as of Q1 2021

As of 31 Mar 2021, REGULUS THERAPEUTICS INC - COM NEW (RGLS) was held by 42 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 27,287,166 shares. The largest 10 holders included NEA Management Company, LLC, VANGUARD GROUP INC, Point72 Asset Management, L.P., Endurant Capital Management LP, VICTORY CAPITAL MANAGEMENT INC, Asymmetry Capital Management, L.P., Sarissa Capital Management LP, Ikarian Capital, LLC, TWO SIGMA INVESTMENTS, LP, and TWO SIGMA ADVISERS, LP. This page lists 42 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.